1. Moein-Vaziri N, Fallahi J, Namavar-Jahromi B, et al. Clinical and genetic-epignetic aspects of recurrent hydatidiform mole: a review of literature. Taiwan J Obstet Gynecol. 2018;57:1–6.
2. Zhong T, Xie X, Zong T, et al. Lectin histochemical analysis of uterine natural killer cells in normal, hydatidiform molar and invasive molar pregnancy. Oncol Lett. 2018;16:6458–64.
3. Albright BB, Shorter JM, Mastroyannis SA, et al. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization following molar pregnancy: a systematic review and meta-analysis. Obstet Gynecol. 2020;135:12–23.
4. Giacometti C, Bellan E, Ambrosi A, et al. “While there is p57, there is hope.” The past and the present of diagnosis in first trimester abortions: diagnostic dilemmas and algorithmic approaches. A review. Placenta. 2021;25:S0143-4004(21)00060-6.
5. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest. 1998;78:269–76.